Consensus document on "antimicrobial treatment of pharyngeal tonsillitis";Documento de consenso sobre "tratamiento antimicrobiano de la faringoamigdalitis"

Acta Otorrinolaringologica Espanola

Volumn 54, Issue 5, 2003, Pages 369-383

  Cenjor, Carlos ^d   Garcia Rodriguez J A ^a   Ramos, A ^b   Cervera, J ^b   Tomas M ^b   Asensi, F ^b   Canada J L ^b   Gobernado, M ^a   Isasia T ^c   Lopez Madronero C ^b   Martinez M ^b   Perez Escanilla F ^b   Picazo, J ^a   Prieto, J ^a   Sampelayo, T ^b  

^a Sociedad Española de Quimioterapia SEQ   (Spain)

^b Sociedad Española de Otorrinolaringología Y Patología Cérvico Facial ^*

^c Sociedad Española de Medicina de Urgencias y Emergencias   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFADROXIL; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN; CLARITHROMYCIN; CLINDAMYCIN; MIOKAMYCIN; PENICILLIN G; ANTIINFECTIVE AGENT;

CONFERENCE PAPER; CONSENSUS; HUMAN; MICROBIOLOGICAL EXAMINATION; PHARYNGITIS; RECURRENT INFECTION; STREPTOCOCCUS PYOGENES; TREATMENT INDICATION; INFORMED CONSENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; REVIEW; STREPTOCOCCUS INFECTION; TONSILLITIS;

ANTI-BACTERIAL AGENTS; HUMANS; INFORMED CONSENT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS;

EID: 0142026790     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-6519(03)78425-8     Document Type: Conference Paper

References (126)

1. CDC. Diphtheria outbreak-Russian Federation, 1990-1993. MMWR Morb Mortal Wkly Rep 1993; 42: 840-841, 847.
2. Romero Vivas J, Sánchez A, Corral O, Rubio M, Picazo JJ. Estudio de las infecciones pediátricas en el medio extrahospitalario. Rev Anales Esp Pediatría 1994; 63: 112-116.
3. Romero Vivas J, Rubio Alonso M, Corral O, Pacheco S, Agudo E, Picazo JJ. Estudio de las infecciones respiratorias extrahospitalarias. Enferm Infecc Microbiol Clin 1997; 15: 289-298.
4. Douglas JW, Waller RE. Air pollution and respiratory infection in Children. Br J Prev Soc Med 1966; 20: 1-11.
5. Colley JR, Douglas JW, Reid DD. Respiratory disease in young adults: influence of early childhood lower respiratory tract illness, social class, air pollution, and smoking. Br Med J 1973; 3: 195-198.
6. Said G, Zalokar J, Lellouch J, Patois E. Parental smoking related to adenoidectomy and tonsillectomy in children. J Epidemiol Community Health 1978; 32: 97-101.
7. Hinton AE, Herdman RC, Martin-Hirsch D, Saeed SR. Parental cigarette smoking and tonsillectomy in children. Clin Otolaryngol 1993; 18: 178-180.
8. Domenighetti G, Bisig BE. Tonsillectomy: a family-transmissible surgical procedure. Lancet 1995; 346: 1376.
9. Hedges JR, Lowe RA. Approach to acute pharyngitis. Emerg Med Clin North Am 1987; 5: 335-351.
10. SOCIMED GdES. Estudio Nacional de la Infección Respiratoria Madrid; 1990.
11. Putto A. Febrile exudative tonsillitis: viral or streptococcal? Pediatrics 1987; 80: 6-12.
12. McMillan JA, Sandstrom C, Weiner LB, Forbes BA, Woods M, Howard T, Poe L, Keller K, Corwin RM, Winkelman JW. Viral and bacterial organisms associated with acute pharyngitis in a school-aged population. J Pediatr 1986; 109: 747-752.
13. Ylikoski J, Karjalainen J. Acute tonsillitis in young men: etiological agents and their differentiation. Scand J Infect Dis 1989; 21: 169-174.
14. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 Suppl: 3-12.
15. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326-335.
16. Komaroff AL, Aronson MD, Pass TM, Ervin CT, Branch WT, Schachter J. Serologic evidence of chlamydial and mycoplasmal pharyngitis in adults. Science 1983; 222: 927-929.
17. Gerber MA, Ryan RW, Tilton RC, Watson JE. Role of Chlamydia trachomatis in acute pharyngitis in young adults. J Clin Microbiol 1984; 20: 993-994.
18. Charnock DR, Chapman GD, Taylor RE, Wozniak A. Recurrent tonsillitis. The role of Chlamydia and Mycoplasma. Arch Otolaryngol Head Neck Surg 1992; 118: 507-508.
19. McCue JD. Group G streptococcal pharyngitis. Analysis of an outbreak at a college. JAMA 1982; 248: 1333-1336.
20. Ryan WJ. Throat infection and rash associated with an unusual Corynebacterium. Lancet 1972; 2: 1345-1347.
21. Banck G, Nyman M. Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis 1986; 154: 1037-1040.
22. Huovinen P, Lahtonen R, Ziegler T, Meurman O, Hakkarainen K, Miettinen A, Arstila P, Eskola J, Saikku P. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med 1989; 110: 612-616.
23. Safak MA, Haberal I, Kilic D, Gocmen H. Necrotizing fasciitis secondary to peritonsillar abscess: a new case and review of eight earlier cases. Ear Nose Throat J 2001; 80: 824-830, 833.
24. Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol 1995; 11: 107-117.
25. Bachiller Luque P, Pérez Castrillon JL, Martin Luquero M, Mena Martin FJ, de la Lama López Areal J, Pérez Pascual P, Mazon MA, Herreros Guilarte V. Descripción preliminar de un brote epidémico de tularemia en Valladolid. Rev Clin Esp 1998; 198: 789-793.
26. Nouwen J, Smets F, Rombaux P, Hamoir M, Sokal EM. Acute tonsillitis as the first manifestation of post-transplant lymphoproliferative disorder. Ann Otol Rhinol Laryngol 2002; 111: 165-168.
27. Rosen G, Samuel J, Vered I. Surface tonsillar microflora versus deep tonsillar microflora in recurrent acute tonsillitis. J Laryngol Otol 1977; 91: 911-913.
28. Brook I, Yocum P, Shah K. Surface vs core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis JAMA. 1980; 244: 1696-1698.
29. Surow JB, Handler SD, Telian SA, Fleisher GR, Baranak CC. Bacteriology of tonsil surface and core in children. Laryngoscope 1989; 99: 261-266.
30. Kurien M, Stanis A, Job A, Brahmadathan, Thomas K. Throat swab in the chronic tonsillitis: how reliable and valid is it? Singapore Med J 2000; 41: 324-326.
31. Colreavy MP, Nanan D, Benamer M, Donnelly M, Blaney AW, O_Dwyer TP, Cafferkey M. Antibiotic prophylaxis post-tonsillectomy: is it of benefit? Int J Pediatr Otorhinolaryngol 1999; 50: 15-22.
32. Kindo AJ, Somu L, Srikanth P, Varadrajan M, Lakshmanan K. Role of surface swab, core swab and fine needle aspiration in isolating the core bacteria in inflammed tonsils. Indian J Pathol Microbiol 2001; 44: 293-295.
33. Brook I. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 2001; 17: 439-442.
34. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601-607.
35. Grahn E, Holm SE, Roos K. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. Scand J Infect Dis 1987; 19: 421-426.
36. Fujimori I, Goto R, Kikushima K, Hisamatsu K, Murakami Y, Yamada T. Investigation of oral alpha-streptococcus showing inhibitory activity against pathogens in children with tonsillitis. Int J Pediatr Otorhinolaryngol 1995; 33: 249-255.
37. Osterlund A, Engstrand L. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium-studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol 1997; 117: 883-888.
38. Bussi M, Carlevato MT, Panizzut B, Omede P, Cortesina G. Are recurrent and chronic tonsillitis different entities? An immunological study with specific markers of inflammatory stages. Acta Otolaryngol Suppl 1996; 523: 112-114.
39. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-1884.
40. Roos K, Grahn E, Lind L, Holm S. Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci. Eur J Clin Microbiol Infect Dis 1989; 8: 318-319.
41. Dagan R, Ferne M, Sheinis M, Alkan M, Katzenelson E. An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin. J Infect Dis 1987; 156: 514-516.
42. Okada N, Tatsuno I, Hanski E, Caparon M, Sasakawa C. Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology 1998; 144 (Pt 11): 3079-3086.
43. Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 1998; 352: 1974-1977.
44. Ebenfelt A. Neutrophils are hyperactive in recurrent tonsillitis. Acta Otolaryngol 2002; 122: 206-209.
45. Garcia Callejo FJ, Orts Alborch MH, Morant Ventura A, Costa Alcacer I, Velert Vila MM, Blay Galaud L. Niveles de superóxido dismutasa amigdalar y eritrocitaria en niños con y sin amigdalitis de repetición. An Esp Pediatr 2002; 56: 310-317.
46. Bisno AL. Acute pharyngitis. N Engl J Med 2001; 344: 205-211.
47. Woodwell DA. National Ambulatory Medical Care Survey. 1998 Summary. Vital and Health Statistics. Series 13, Data From the National Health Survey 2000.
48. Bisno AL. Streptococcus pyogenes. In: Mandell GL, Douglas, R. G., Bennett, J. E., eds., ed. Infectious Diseases. New York 1990:1519-1528.
49. Bronze MS, Dale JB. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci 1996; 311: 41-54.
50. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96: 758-764.
51. Givner LB, Abramson JS, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991; 118: 341-346.
52. Pichichero ME. Group A beta-hemolytic streptococcal infections. Pediatr Rev 1998; 19: 291-302.
53. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33: 806-814.
54. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 574-583.
55. Bisno AL, Peter GS, Kaplan EL. Diagnosis of strep throat in adults: are clinical criteria really good enough? Clin Infect Dis 2002; 35: 126-129.
56. Hoffmann S. An algorithm for a selective use of throat swabs in the diagnosis of group A streptococcal pharyngo-tonsillitis in general practice. Scand J Prim Health Care 1992; 10: 295-300.
57. Meland E, Digranes A, Skjaerven R. Assessment of clinical features predicting streptococcal pharyngitis. Scand J Infect Dis 1993; 25: 177-183.
58. Nawaz H, Smith DS, Mazhari R, Katz DL. Concordance of clinical findings and clinical judgment in the diagnosis of streptococcal pharyngitis. Acad Emerg Med 2000; 7: 1104-1109.
59. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113-125.
60. Gwaltney JM, Bisno AL. Pharyngitis. In: Mandell GL, Douglas RG, Bennett JE, Dolin R. Eds. Mandell, Douglas and Bennett's, ed. Principles and Practice of Infectious Diseases. 5 ed. Philadelphia 2000:656-662.
61. Lauer BA, Reller LB, Mirrett S. E ffect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures. J Clin Microbiol 1983; 17: 338-340.
62. Schwartz RH, Gerber MA, McCoy P. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures. J Lab Clin Med 1985; 106: 88-92.
63. Komaroff AL, Pass TM, Aronson MD, Ervin CT, Cretin S, Winickoff RN, Branch WT. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med 1986; 1: 1-7.
64. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA 2001; 286: 1181-1186.
65. Keahey L, Bulloch B, Jacobson R, Tenenbein M, Kabani A. Diagnostic accuracy of a rapid antigen test for GABHS performed by nurses in a pediatric ED. Am J Emerg Med 2002; 20: 128-130.
66. Tsevat J, Kotagal UR. Management of sore throats in children: a cost-effectiveness analysis. Arch Pediatr Adolesc Med 1999; 153: 681-688.
67. Catanzaro FJ, Stetson CA, Morris LJ, Chamovitz IR, Rammelkamp CHJ, Stolzer BL. Symposium on rheumatic fever and rheumatic heart disease: the role of the Streptococcus in the pathogenesis of rheumatic fever. Am J Med 1951; 17: 149-156.
68. Bass JW. Antibiotic management of group A streptococcal pharyngotonsillitis. Pediatr Infect Dis J 1981; 10: 543-549.
69. Gerber MA, Markowitz M. Management of streptococcal pharyngitis reconsidered. Pediatr Infect Dis 1985; 4: 518-526.
70. Jersild T. Penicillin therapy in scarlet fever and complicating otitis. Lancet 1948; 1: 671-673.
71. Breese BB. Treatment of beta hemolytic streptococcal infections in the home: Relative value of available methods. JAMA 1953; 521: 10-14.
72. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985; 253: 1271-1274.
73. Randolph MF, Gerber MA, De Meo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985; 106: 870-875.
74. Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis 1984; 3: 10-13.
75. Betriu C, Sánchez A, Gómez M, Cruceyra A, Picazo JJ. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother 1993; 37: 1717-1719.
76. Baquero F, García Rodríguez JA, de Lomas JG, Aguilar L. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother 1999; 43: 178-180.
77. Gerber MA, Randolph MF, Chanatry J, Wright LL, De Meo K, Kaplan EL. Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child 1987; 141: 224-227.
78. Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A betahemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr (Phila) 1985; 24: 331-336.
79. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium. J Antimicrob Chemother 1989; 24: 227-233.
80. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113: 400-403.
81. Rosenstein BJ, Markowitz M, Goldstein E, Kramer I, O Mansky B, Seidel H, Sigler A, Tramer A. Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr 1968; 73: 513-520.
82. Romero Vivas J, Betriu C, Sánchez ML, Herranz B, Picazo JJ. Estudio de las bacterias productoras de betalactamasa en la flora faríngea en pacientes con faringitis aguda. Enferm Infecc Microbiol Clin 1995; 13: 33-39.
83. Tanz RR, Shulman ST, Sroka PA, Marubio S, Brook I, Yogev R. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990; 117: 859-863.
84. Betriu C, Campos E, Cabronero C, Fernández A, Picazo JJ, Noriega AR. Penicillin tolerance of group A streptococci. Eur J Clin Microbiol Infect Dis 1989; 8: 799-800.
85. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681-684.
86. Revital Neeman, Nattan Keller, Asher Barzilai, Zinaida Korenman, Shlomo Sela. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. The Lancet 1998; 352: 1974-77.
87. Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA 1981; 246: 1790-1795.
88. Bisno AL. Primary prevention of acute rheumatic fever: Quo vadis? J Lab Clin Med 1981; 98: 323-325.
89. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 1993; 306: 1170-1172.
90. Feder HM, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999; 103: 47-51.
91. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial cop athogenicity. Pediatr Infect Dis J 1991; 10: 275-281.
92. McCarty JM, Rentería A. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials. Clin Infect Dis 1992; 14 Suppl 2: S224-230; discussion S231-222.
93. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680-695.
94. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J 1992; 11: 919-925.
95. Adam D, Hostalek U, Troster K. 5 - Tagestherapie der bakteriellen Pharyngitis und Tonsillitis mit Cefixim. Vergleich zu einer 10tgigen Behandlung mit Penicillin V. Cefixim Studiengruppe. Klin Padiatr 1996; 208: 310-313.
96. McCarty JM. Comparative eff icacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis 1994; 13: 846-850.
97. Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 1999; 43: 1935-1940.
98. Tzelepi E, Kouppari G, Mavroidi A, Zaphiropoulou A, Tzouvelekis LS. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J Antimicrob Chemother 1999; 43: 745-746.
99. Kataja J, Huovinen P, Skurnik M, Seppäla H. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999; 43: 48-52.
100. Betriu C, Casado MC, Gómez M, Sánchez A, Palau ML, Picazo JJ. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn Microbiol Infect Dis 1999; 33: 255-260.
101. García Bermejo I, Cacho J, Orden B, Alos JI, Gómez Garcés JL. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother 1998; 42: 989-990.
102. Pérez Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25-31.
103. Bellido JL, García Saenz JA, Manzanares MA, Gutiérrez Zufiaurre MN, García Rodríguez JA. Resistencia a los macrólidos en Streptococcus pyogenes. Rev Esp Quimioter 1998; 11: 196-204.
104. Seppäla H, Klaukka T, Vuopio Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441-446.
105. Granizo JJ, Aguilar L, Casal J, Dal Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959-964.
106. McCarty J, Hedrick JA, Gooch WM. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. Adv Ther 2000; 17: 14-26.
107. Still JG. Management of pediatric patients with group A beta-hemolytic Streptococcus pharyngitis: treatment options. Pediatr Infect Dis J. 1995; 14(Suppl 3A): S57-S61.
108. Betriu C, Culebras E, Redondo M, Rodriguez Avial I, Gómez M, Boloix A, Picazo JJ. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin. J Antimicrob Chemother 2002; 50: 436-438.
109. Giovanetti E, Montanari MP, Marchetti F, Varaldo PE. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother 2000; 46: 905-908.
110. Jalava J, Kataja J, Seppäla H, Huovinen P. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother 2001; 45: 789-793.
111. Bemer-Melchior P, Juvin ME, Tassin S, Bryskier A, Schito GC, Drugeon HB. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother 2000; 44: 2999-3002.
112. Brook I, Gober AE. Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr (Phila) 1984; 23: 338-341.
113. Mehra S, van Moerkerke M, Welck J, Sverrisson G, Sirotiakova J, Marr C, Staley H. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J 1998; 17: 452-457.
114. Pichichero ME, Gooch WM, Rodriguez W, Blumer JL, Aronoff SC, Jacobs RF, Musser JM. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med 1994; 148: 1053-1060.
115. Gerber MA, Tanz RR. New approaches to the treatment of group A streptococcal pharyngitis. Curr Opin Pediatr. 2001; 13: 51-55.
116. Kaplan EL, Gooch III WM, Notario GF, Craft JC. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). Clin Infect Dis. 2001; 32: 1798-1802.
117. Norrby SR, Rabie WJ, Bacarat P, Mueller O, Leroy B, Rangaraju M, Butticaz-Iroudayassamy E. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treament of pharyngitis/tonsillitis. Scand J Infect Dis 2002; 33: 883-890.
118. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr 1980; 97: 337-345.
119. Gerber MA, Randolph MF, Mayo DR. The group A streptococcal carrier state. A reexamination. Am J Dis Child 1988; 142: 562-565.
120. Betriu C, Romero J, Sánchez A, Sánchez ML, Gómez M, Picazo JJ. Estudio del estado de portador de estreptococos betahemolí ticos de los grupos A, B, C y G. Enferm Infecc Microbiol Clin 1994; 12: 285-288.
121. Tuner K, Nord CE. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis. Ann Otol Rhinol Laryngol 1994; 94: 278-280.
122. Foote PA, Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora. Arch Otolaryngol Head Neck Surg 1989; 115: 856-859.
123. Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, Bisno AL. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106: 481-486.
124. Milatovic D, Knauer J. Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 1989; 8: 282-288.
125. Llorente pendás JL. Suárez C. Indicaciones de amigdalectomía. Bol Pediatr 1999; 39: 72-75.
126. Darrows DH, Siemens C. Indications for tonsillectomy and adenoidectomy. Laringoscope 2002; 112(8pt 2): 6-10.